{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:22:17Z","timestamp":1780582937604,"version":"3.54.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032339","name":"BioNTech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinthera.2025.07.006","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T11:09:42Z","timestamp":1755947382000},"page":"770-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of Severe Outcomes From COVID-19 in Immunocompromised People During the Omicron Era: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"Akvile","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllos","family":"Pliakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Abduljawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.07.006_bib0001","unstructured":"World Health Organization. WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). Accessed July 3, 2024. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov)."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0002","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report \u201351. Accessed July 3, 2024. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0003","unstructured":"World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. Accessed July 3, 2024. Available from: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0004","unstructured":"World Health Organization. WHO COVID-19 Dashboard. Accessed August 16, 2024. Available from: https:\/\/data.who.int\/dashboards\/covid19\/."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0005","unstructured":"World Health Organization. WHO Director-General's opening remarks at the media briefing \u20135 May 2023. Accessed July 3, 2024. Available from: https:\/\/www.who.int\/news-room\/speeches\/item\/who-director-general-s-opening-remarks-at-the-media-briefing\u20145-may-2023."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0006","unstructured":"Centers for Disease Control and Prevention. COVID-19 can surge throughout the year. Accessed August 16, 2024. Available from: https:\/\/www.cdc.gov\/ncird\/whats-new\/covid-19-can-surge-throughout-the-year.html."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0007","unstructured":"World Health Organization. Risk evaluation for SARS-CoV-2 variant under monitoring: NB.1.8.1. Accessed July 1, 2025. Available from: https:\/\/www.who.int\/publications\/m\/item\/risk-evaluation-for-sars-cov-2-variant-under-monitoring-nb.1.8.1."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2023.01.027","article-title":"Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022)","volume":"129","author":"Petrone","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0009","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(22)00154-2","article-title":"Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study","volume":"22","author":"Bager","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0011","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.4.2200077","article-title":"Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022","volume":"27","author":"Veneti","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0012","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1473-3099(22)00141-4","article-title":"EAVE II Collaborators. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design","volume":"22","author":"Sheikh","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0013","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1038\/s41467-023-39661-5","article-title":"Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England","volume":"14","author":"Perez-Guzman","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0014","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis","volume":"8","author":"Pryanka","year":"2023","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0015","article-title":"Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom","volume":"25","author":"Hyams","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25665","article-title":"Association between the relaxation of public health and social measures and transmission of the SARS-CoV-2 Omicron variant in South Korea","volume":"5","author":"Ryu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0017","series-title":"The public health response by UK governments to COVID-19","year":"2022"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jinf.2021.01.022","article-title":"COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients","volume":"82","author":"Belsky","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004086","article-title":"Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study","volume":"20","author":"Turtle","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0020","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0021","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/infdis\/jiad181","article-title":"The burden of COVID-19 in the immunocompromised patient: implications for vaccination and needs for the future","volume":"228","author":"Antinori","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0022","doi-asserted-by":"crossref","first-page":"eadk1599","DOI":"10.1126\/scitranslmed.adk1599","article-title":"SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0023","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir resistance in transplant recipients with persistent Coronavirus Disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0024","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0025","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2468-2667(23)00079-8","article-title":"Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform","volume":"8","author":"Nab","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0027","unstructured":"The World Bank. World Bank Country and Lending Groups. Accessed 26 June, 2025. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0028","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0029","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jiph.2022.09.005","article-title":"COVID-19 vaccine had a significant positive impact on patients with SARS-COV-2 during the third (Omicron) wave in Saudi Arabia","volume":"15","author":"AlBahrani","year":"2022","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0030","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41591-022-01832-0","article-title":"Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60\u2009years","volume":"28","author":"Arbel","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0031","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1473-3099(23)00122-6","article-title":"Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study","volume":"23","author":"Arbel","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0032","article-title":"COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada","volume":"20","author":"Bahremand","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0033","article-title":"A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave","volume":"9","author":"Bao","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0034","article-title":"Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales","volume":"37","author":"Bedston","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/diseases11030119","article-title":"Survival analysis and contributing factors among PCR-confirmed adult inpatients during the endemic phase of COVID-19","volume":"11","author":"Benites-God\u00ednez","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1744-9987.14067","article-title":"Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemics","volume":"28","author":"Beppu","year":"2024","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0037","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cmi.2022.12.020","article-title":"Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)","volume":"29","author":"Beraud","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0038","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/rheumatology\/kead354","article-title":"Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study","volume":"63","author":"Bournia","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0039","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/healthcare11030373","article-title":"Comparison of COVID-19 severity in vaccinated and unvaccinated patients during the Delta and Omicron wave of the pandemic in a Romanian tertiary infectious diseases hospital","volume":"11","author":"Briciu","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0040","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1093\/cid\/ciac501","article-title":"Hospitalized patients with severe coronavirus disease 2019 during the Omicron wave in Israel: benefits of a fourth vaccine dose","volume":"76","author":"Brosh-Nissimov","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0041","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1186\/s12877-023-04487-9","article-title":"Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0042","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jmii.2024.01.006","article-title":"Clinical characteristics and treatment outcomes among the hospitalized elderly patients with COVID-19 during the late pandemic phase in central Taiwan","volume":"57","author":"Chen","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0043","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.3346\/jkms.2023.38.e65","article-title":"Clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and Omicron variant-dominant periods in Korea","volume":"38","author":"Choi","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0044","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41467-022-33801-z","article-title":"Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19","volume":"13","author":"de Prost","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40635-023-00536-0","article-title":"Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study","volume":"11","author":"de Prost","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0046","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/vaccines11101568","article-title":"Profile and outcomes of hospitalized COVID-19 patients during the prevalence of the Omicron variant according to the Brazilian regions: a retrospective cohort study from 2022","volume":"11","author":"Drummond","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0047","doi-asserted-by":"crossref","first-page":"179","DOI":"10.15537\/smj.2024.45.2.20230530","article-title":"Impact of vaccination on morbidity and mortality in adults hospitalized with COVID-19 during the Omicron wave in the Jazan Region, Saudi Arabia","volume":"45","author":"Elamin","year":"2024","journal-title":"Saudi Med J"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0048","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5694\/mja2.51813","article-title":"Factors associated with hospitalisations and deaths of residential aged care residents with COVID-19 during the Omicron (BA.1) wave in Queensland","volume":"218","author":"Ellis","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0049","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/odi.14515","article-title":"Relationship between oral lesions and severe SARS-CoV-2 infection in intensive care unit patients","volume":"30","author":"Favia","year":"2024","journal-title":"Oral Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0050","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/v15091794","article-title":"Predictors of SARS-CoV-2 infection and severe and lethal COVID-19 after three years of follow-up: a population-wide study","volume":"15","author":"Flacco","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071113","article-title":"Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study","volume":"377","author":"Gazit","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0052","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciad505","article-title":"Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 states, June 2021-March 2023","volume":"78","author":"Griggs","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0053","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s12879-023-08620-2","article-title":"In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0054","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10877-023-00989-4","article-title":"Parasternal intercostal thickening at hospital admission: a promising indicator for mechanical ventilation risk in subjects with severe COVID-19","volume":"37","author":"Helmy","year":"2023","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072976","article-title":"Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study","volume":"381","author":"Hippisley-Cox","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28607","article-title":"Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: a national cohort study in Iran","volume":"95","author":"Jamaati","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0057","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijid.2023.06.016","article-title":"Severe coronavirus disease 2019 in pediatric solid organ transplant recipients: big data convergence study in Korea (K-COV-N cohort)","volume":"134","author":"Kang","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0058","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.3390\/jcm12185904","article-title":"Patients hospitalized for COVID-19 in the periods of Delta and Omicron variant dominance in Greece: determinants of severity and mortality","volume":"12","author":"Karageorgou","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0059","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3390\/jcm12062279","article-title":"Clinical outcome and prognosis of a nosocomial outbreak of COVID-19","volume":"12","author":"Kim","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105500","article-title":"Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis","volume":"165","author":"Klein","year":"2023","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0061","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000529788","article-title":"High in-hospital mortality in SARS-CoV-2-infected patients with active cancer disease during Omicron phase of the pandemic: insights from the CORONA Germany study","volume":"46","author":"Konermann","year":"2023","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0062","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/23744235.2023.2276784","article-title":"Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era","volume":"56","author":"Lee","year":"2024","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0063","article-title":"Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic","volume":"10","author":"Li","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1320340","article-title":"Clinical features of omicron SARS-CoV-2 variants infection associated with co-infection and ICU-acquired infection in ICU patients","volume":"11","author":"Li","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0065","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.2147\/IJGM.S425567","article-title":"Combination of chest computed tomography value and clinical laboratory data for the prognostic risk evaluation of patients with COVID-19","volume":"16","author":"Liu","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0066","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1080\/22221751.2022.2109517","article-title":"Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave","volume":"11","author":"Lu","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0067","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/ene.15843","article-title":"History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational study","volume":"30","author":"Mayer","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0068","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3390\/vaccines11101512","article-title":"Association between vaccination status for COVID-19 and the risk of severe symptoms during the endemic phase of the disease","volume":"11","author":"Mendoza-Cano","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0069","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/biomedicines11030767","article-title":"Risk stratification model for severe COVID-19 disease: a retrospective cohort study","volume":"11","author":"Mizrahi Reuveni","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0070","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/ciac885","article-title":"Omicron subvariants: clinical, laboratory, and cell culture characterization","volume":"76","author":"Morris","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0071","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3390\/v14122736","article-title":"Severity of COVID-19 among hospitalized patients: Omicron remains a severe threat for immunocompromised hosts","volume":"14","author":"Nevejan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0072","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ajic.2022.08.033","article-title":"Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance","volume":"51","author":"O'Leary","year":"2023","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0073","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/ajt.17142","article-title":"Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study","volume":"22","author":"Overvad","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0074","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1017\/cts.2023.594","article-title":"Fibrosis-4 (FIB-4) index as a predictor for mechanical ventilation and 30-day mortality across COVID-19 variants","volume":"7","author":"Parajuli","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.puhe.2022.12.006","article-title":"Comparative analysis of risk factors for COVID-19 mortality before, during and after the vaccination programme in Mexico","volume":"215","author":"Parra-Bracamonte","year":"2023","journal-title":"Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0076","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13054-023-04312-0","article-title":"COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation","volume":"27","author":"Patton","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0077","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijid.2023.06.026","article-title":"Risk of COVID-19 hospitalization in people living with HIV and HIV-negative individuals and the role of COVID-19 vaccination: a retrospective cohort study","volume":"135","author":"Puyat","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0078","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12879-023-08714-x","article-title":"Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service","volume":"23","author":"Radhakrishnan","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0079","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAD.0000000000003393","article-title":"Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in Denmark","volume":"37","author":"Rasmussen","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0080","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1016\/S2665-9913(22)00216-8","article-title":"COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study","volume":"4","author":"Risk","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0081","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28423","article-title":"Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population-based cohort study in British Columbia, Canada","volume":"95","author":"Russell","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0082","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jiph.2023.10.016","article-title":"Factors associated with COVID-19 brought-in deaths: a data-linkage comparative cross-sectional study","volume":"16","author":"Shakor","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0083","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.3346\/jkms.2023.38.e217","article-title":"Clinical characteristics and risk factors for mortality in critical COVID-19 patients aged 50 years or younger during Omicron wave in Korea: comparison with patients older than 50 years of age","volume":"38","author":"Shi","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283715","article-title":"Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: a retrospective cohort study","volume":"18","author":"Simmons","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0085","article-title":"Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: a retrospective cohort study","volume":"12","author":"Skarbinski","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0086","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36990-9","article-title":"A population-scale temporal case\u2013control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)","volume":"13","author":"Starkey","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0087","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/ard-2023-223974","article-title":"Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study","volume":"82","author":"Svensson","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0088","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/fampra\/cmad010","article-title":"Outcomes in novel hospital-at-home model for patients with COVID-19: a multicentre retrospective cohort study","volume":"40","author":"Tsujimoto","year":"2023","journal-title":"Fam Pract"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40037","article-title":"Factors associated with severe COVID-19 among vaccinated adults treated in US veterans affairs hospitals","volume":"5","author":"Vo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/infdis\/jiac460","article-title":"Impact of vaccination, prior infection, and therapy on Omicron infection and mortality","volume":"227","author":"Wang","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0091","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41467-023-44276-x","article-title":"Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England","volume":"15","author":"Ward","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1330106","article-title":"Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients","volume":"11","author":"Xin","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0093","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2147\/CIA.S417282","article-title":"Variables associated with 30-day mortality in very elderly COVID-19 patients","volume":"18","author":"Xing","year":"2023","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0094","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28977","article-title":"Clinical characteristics and factors for serious outcomes among outpatients infected with the Omicron subvariant BF.7","volume":"95","author":"Yang","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1031231","article-title":"A practical scoring model to predict the occurrence of critical illness in hospitalized patients with SARS-CoV-2 omicron infection","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0096","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s40121-023-00845-7","article-title":"Is azvudine comparable to nirmatrelvir-ritonavir in real-world efficacy and safety for hospitalized patients with COVID-19? a retrospective cohort study","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0097","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12890-023-02473-w","article-title":"Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0098","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1136\/annrheumdis-2020-219821","article-title":"Correspondence on `Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'","volume":"82","author":"Yang","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0099","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044661","article-title":"Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis","volume":"12","author":"Han","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74634","article-title":"Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients","volume":"11","author":"Di Felice","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0101","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.017","article-title":"Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis","volume":"81","author":"Gao","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0102","doi-asserted-by":"crossref","DOI":"10.1177\/2040622321998860","article-title":"Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"12","author":"Lin","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100628","article-title":"The association between severe or death COVID-19 and solid organ transplantation: a systematic review and meta-analysis","volume":"35","author":"Ao","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0104","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.chest.2021.12.654","article-title":"Impaired SARS-CoV-2 mRNA vaccine antibody response in chronic medical conditions: a real-world analysis","volume":"161","author":"Liao","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0105","doi-asserted-by":"crossref","first-page":"00400","DOI":"10.1183\/23120541.00400-2023","article-title":"Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients","volume":"9","author":"Liu","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0107","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0108","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"6","author":"Lim","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103409","article-title":"Increased incidence of rheumatoid arthritis after COVID-19","volume":"22","author":"Marin","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3899\/jrheum.200989","article-title":"Risk of adverse outcomes in hospitalized patients with autoimmune disease and COVID-19: a matched cohort study from New York City","volume":"48","author":"Faye","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0111","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152149","article-title":"Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)","volume":"58","author":"Singh","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0113","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0114","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s40001-023-01403-0","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis","volume":"28","author":"Sun","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0115","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(22)00273-X","article-title":"Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study","volume":"23","author":"Pinato","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0116","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12032-021-01553-3","article-title":"Cancer and COVID-19: why are cancer patients more susceptible to COVID-19?","volume":"38","author":"Sinha","year":"2021","journal-title":"Med Oncol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0118","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-023-01432-6","article-title":"Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients","volume":"16","author":"Leyfman","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0119","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10238-023-01004-5","article-title":"Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis","volume":"23","author":"Hardy","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12325-023-02754-0","article-title":"Assessing the burden and cost of COVID-19 across variants in commercially insured immunocompromised populations in the United States: updated results and trends from the ongoing EPOCH-US study","volume":"41","author":"Ketkar","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ckj\/sfaa104","article-title":"Coronavirus disease 2019 in chronic kidney disease","volume":"13","author":"D'Marco","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0122","first-page":"2137","article-title":"COVID-19 and kidney: the importance of follow-up and long-term screening","volume":"13","author":"Rai","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0123","doi-asserted-by":"crossref","first-page":"sfad283","DOI":"10.1093\/ckj\/sfad283","article-title":"Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study","volume":"17","author":"Artborg","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0124","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10157-022-02180-6","article-title":"Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19","volume":"26","author":"Gur","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13421","article-title":"COVID-19 in solid organ transplant recipients: no difference in survival compared to general population","volume":"23","author":"Rinaldi","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0126","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/ajt.16424","article-title":"Is COVID-19 infection more severe in kidney transplant recipients?","volume":"21","author":"Caillard","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0127","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/ajt.16369","article-title":"COVID-19 in transplant recipients: the Spanish experience","volume":"21","author":"Coll","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0128","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis","volume":"11","author":"Ssentongo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12981-021-00427-y","article-title":"Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis","volume":"19","author":"Danwang","year":"2022","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0130","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1016\/S2352-3018(21)00272-1","article-title":"More evidence for worse COVID-19 outcomes in people with HIV","volume":"8","author":"Boffito","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0131","unstructured":"Centers for Disease Control and Prevention. Vaccines for moderately to severely immunocompromised people. Accessed October 1, 2024. Available from: https:\/\/www.cdc.gov\/covid\/vaccines\/immunocompromised-people.html."},{"key":"10.1016\/j.clinthera.2025.07.006_bib0132","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s40121-024-01051-9","article-title":"Delphi panel consensus statement generation: COVID-19 vaccination recommendations for immunocompromised populations in the European Union","volume":"13","author":"Paranilam","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0133","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/vaccines11121813","article-title":"COVID-19 vaccination and immunosuppressive therapy in immune-mediated inflammatory diseases","volume":"11","author":"Serra Lopez-Matencio","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0134","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: Version 5","volume":"75","author":"Curtis","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0135","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.annonc.2020.07.010","article-title":"Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0136","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.70470\/EDRAAK\/2023\/007","article-title":"A review of approaches and difficulties in the use of deep learning techniques for COVID-19 disease diagnosis on chest X-rays","volume":"2023","author":"abud-allah","year":"2023","journal-title":"EDRAAK"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0138","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm7113e1","article-title":"Use of at-home COVID-19 tests - United States, August 23, 2021-March 12, 2022","volume":"71","author":"Rader","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0139","doi-asserted-by":"crossref","first-page":"985","DOI":"10.15585\/mmwr.mm7028a1","article-title":"COVID-19 vaccination coverage among insured persons aged >\/=16 years, by race\/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2025.07.006_bib0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7103e1","article-title":"Racial and ethnic disparities in receipt of medications for treatment of COVID-19 - United States, March 2020-August 2021","volume":"71","author":"Wiltz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:23:01Z","timestamp":1777490581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":140,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0149291825002437"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.07.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Severe Outcomes From COVID-19 in Immunocompromised People During the Omicron Era: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}